HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice

Rajeev K. Tyagi(Vanderbilt University Medical Center), Jeremy A. Goettel(Vanderbilt University Medical Center), Keith T. Wilson(VA Tennessee Valley Healthcare System), Kevin L. Otipoby(Boston Biomedical Research Institute), Jing Li(Guangzhou University of Chinese Medicine), Justin Jacobse(Leiden University Medical Center), Erik R. Sampson(Legacy Health), Margaret M. Allaman(Vanderbilt University Medical Center)
Frontiers in Immunology
February 24, 2021
10.3389/fimmu.2021.630204
Cited by 22

Related Papers

Generation of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic Cells
|Science|2006|999
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
|Cell|2009|651
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
|Cell|2020|640
B cell receptor signal strength determines B cell fate
|Nature Immunology|2004|556
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
|Cell|2021|338